POOR LONG-TERM OUTCOME OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2
Kupitz, Elke H., Heeren, Tjebo F. C., Holz, Frank G., Charbel Issa, PeterVolume:
35
Language:
english
Journal:
Retina
DOI:
10.1097/iae.0000000000000715
Date:
December, 2015
File:
PDF, 1.18 MB
english, 2015